RNA-based Therapeutics
Shape Therapeutics RNAfix® Editing Platform Achieves >90% Editing in Mouse and Non-Human Primate Brain
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer(TM) RNA Editing Program Targeting NTCP for Cholestatic Diseases
Robust Financial Health and Promising Clinical Trials Bolster Buy Rating for Dyne Therapeutics
Alnylam Pharmaceuticals
Scientists reveal how SID-1 recognizes dsRNA and initiates systemic RNA interference
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
RNA Nanotechnology
RNA's hidden potential: New study unveils its role in early life and future bioengineering
Nanotechnology News
A promising target for new RNA therapeutics now accessible
11 Best Nanotechnology Stocks To Invest In
Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung disease
RNA News and Research
Nanotechnology in Therapeutics
Improving Gene Therapy for Lung Disease
RNA Vaccines
mRNA vaccine tackles deadly brain cancer in human trial
Human RNome Project: World-Renowned Scientists Call for RNA Counterpart to Human Genome Project
RNA
Large amount of bird flu virus in milk suggests asymptomatic cows are infected with H5N1
Google’s AlphaFold 3 AI predicts the very building blocks of life